JAN 27, 2016 01:29 PM PST

Activating Dendritic Cells with Optogenetic Immunomodulation Technology

WRITTEN BY: Kara Marker
Optogenetics is a technology used by neuroscientists to follow and record the course of individual neurons as they fire. Using different colors of light to stimulate activity, scientists can learn more about the inner workings of animal brains. Scientists from the University of Massachusetts Medical School, in collaboration with scientists from Texas A&M Science Center Institute of Biosciences & Technology, thought that this technology could also be incorporated into a new cancer immunotherapy, and they were right.
 


Although lymphocytes do not fire action potentials to communicate with each other like neurons do, they have their own methods for cell signaling. Together, scientists from both universities developed an optogenetic immunomodulation technology that relies on the regular flow of calcium ions through channels on the surface of dendritic cells.
 
Dendritic cells play a vital role in an immune attack. By responding to infection with displaying antigens on their cell surface, T cells are alerted of an invasion and instruct B cells to make antibodies targeting the invader. Scientists conducting this study, published recently in the journal eLife, used mouse models of melanoma to see if their new optogenetic immunomodulation technology could activate dendritic cells to attack melanoma tumors.
 
 First, Texas A&M scientists equipped dendritic cells with a light-sensitive calcium gate-controlling protein. These cells’ calcium channel gates then respond to blue light, either opening with the light on or closing with the light off. When the gates open, calcium ions flood in and activate the dendritic cell. With the light off, the gates close and the dendritic cell returns or stays in a dormant-like state.
 
Next, University of Massachusetts scientists made these equipped dendritic cells accessible to light within an animal by developing a nanoparticle to attach to the cells that converts “near-infrared light” into the visible blue light to be used for controlling calcium ion channels. The near-infrared light can infiltrate tissue up to two centimeters. The dendritic cells and attached nanoparticles are called “opto-CRAC.”
 
“We now have the tools to closely monitor the dose and location of [cancer] treatment to mitigate potential side effects to healthy tissues,” said author of the study Gang Han, PhD, from the University of Massachusetts.
 
With their technology in place, the team was able to test their control over dendritic cell activation with calcium ion channel regulation. They introduced opto-CRAC into mouse models of melanoma as well as the “tumor antigen surrogate” ovalbumin. The tumor antigen component is required for dendritic cell activation of T cells, should the new technology prove to be successful.
 
The new optogenetic immunomodulation technology was indeed successful:
 

"We saw significantly suppressed tumor growth and reduced tumor volume in these animals,” Han said. “This suggests that the activated dendritic cells were successfully programming T-cells to attack the tumor.”

 
Further success with this technology could lead to less invasive cancer treatments, since specific cells and tissues compromised by cancer can be targeted, and healthy tissue can be left alone.
 
 
Source: University of Massachusetts Medical School
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUN 02, 2018
Immunology
JUN 02, 2018
New Test Predicts Lupus Onset
Based on several different factors, scientists have a new risk index for predicting who will develop lupus. From the Feinstein Institute for Medical Resear...
JUN 13, 2018
Health & Medicine
JUN 13, 2018
Insurance Denials Prevent Patients From Getting Hep C Medication
Some ads are running on television and in major magazines about drugs for hepatitis C, known as Hep C or HCV. Available in the United States since 2014, th...
JUN 21, 2018
Immunology
JUN 21, 2018
The Silver Tsunami: An Aging Immune System and Cancer
Why do cases of cancer become more common as we get older? Scientists interested in explaining the so-called “Silver Tsunami” phenomenon look t...
JUN 28, 2018
Immunology
JUN 28, 2018
Synthetic T Cells the Next Big Thing in Immunotherapy
The highly complex structure and function of human T cells made the creation of synthetic versions of the immune cells difficult, but scientists from Unive...
AUG 18, 2018
Immunology
AUG 18, 2018
Two Proteins Play Unexpected Role in Immune System Regulators
Two proteins, PLD3 and PLD4, discovered to have role in immune system detection and response to pathogens....
SEP 07, 2018
Health & Medicine
SEP 07, 2018
What's Behind the Massive Measles Outbreak in Europe?
Measles is a disease that many believe was eradicated years ago. That's true, to a point, but like a bad penny, it's back. In the United States, th...
Loading Comments...